Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of the Female Reproductive System

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...

Uterus and Cervix

Uterus and Cervix

The uterus, commonly called the womb, is a vital reproductive organ in females designed to provide a nurturing environment for the implantation and growth of an embryo. It is shaped like a hollow pear and positioned between the urinary bladder and the rectum. The uterus's structure allows it to support and protect a developing fetus throughout pregnancy.
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs of...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

What is Cancer?

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

Rheumatoid arthritis: previously untreated early disease.

BMJ clinical evidence·2016

Same journal

Diabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema.

BMJ clinical evidence·2016

Same journal

Subarachnoid haemorrhage (spontaneous aneurysmal).

BMJ clinical evidence·2016

Same journal

Malaria: fluid therapy in severe disease.

BMJ clinical evidence·2016

Same journal

Age-related macular degeneration: anti-vascular endothelial growth factor treatment.

BMJ clinical evidence·2016

Same journal

MRSA: treating people with infection.

BMJ clinical evidence·2016

See all related articles

Search research articles

Related Experiment Video

Updated: May 30, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Cervical cancer.

Pierre Leonard Martin-Hirsch¹, Nicholas James Wood

¹Department of Gynaecology, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.

BMJ Clinical Evidence

|July 28, 2011

Summary

This summary is machine-generated.

This systematic review evaluates interventions for preventing and managing cervical cancer. It covers HPV vaccination, surgical options for early-stage disease, and various treatments for bulky early-stage cervical cancer.

More Related Videos

Generation and Genetic Manipulation of Human Cervical Organoids

Generation and Genetic Manipulation of Human Cervical Organoids

Published on: March 10, 2026

Related Experiment Videos

Last Updated: May 30, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Generation and Genetic Manipulation of Human Cervical Organoids

Generation and Genetic Manipulation of Human Cervical Organoids

Published on: March 10, 2026

Area of Science:

Oncology
Gynecologic Oncology
Public Health

Background:

Cervical cancer is a significant global health concern, ranking as the third most common cancer in women worldwide.
While screening programs have reduced incidence in the UK, survival rates vary dramatically based on disease stage, from nearly 100% for stage Ia to 5-15% for stage IV.
Tumor bulk, patient age, and comorbidities also impact survival outcomes.

Purpose of the Study:

To systematically review the effectiveness and safety of interventions for cervical cancer prevention.
To assess interventions for managing early-stage and bulky early-stage cervical cancer.
To answer key clinical questions regarding the impact of various treatment modalities.

Main Methods:

A comprehensive systematic review was conducted, searching major databases including Medline, Embase, and The Cochrane Library up to October 2009.
Included studies comprised systematic reviews, randomized controlled trials (RCTs), and observational studies.
Harms alerts from regulatory agencies like the FDA and MHRA were also incorporated.

Main Results:

Fourteen systematic reviews, RCTs, or observational studies met the inclusion criteria for the review.
A GRADE evaluation was performed to assess the quality of evidence for the included interventions.
Information on the effectiveness and safety of various interventions was compiled.

Conclusions:

The review presents data on human papillomavirus (HPV) vaccine for cervical cancer prevention.
It details interventions for microinvasive and early-stage cervical cancer, including conization, lymphadenectomy, and radical trachelectomy.
Effectiveness and safety of neoadjuvant chemotherapy, radiotherapy, chemoradiotherapy, and different hysterectomy types for early and bulky early-stage disease are discussed.